Leading the way in Parkinson’s research

Since 1981, the Parkinson Canada Research Program has invested more than $27 million in funding for:

  • High-quality, innovative Canadian research by established and promising investigators.
  • Discovery stage research where investigators test new theories and pursue promising new leads.
  • Researchers at the beginning of their careers in order to foster the next generation of Parkinson’s scientists.
  • Novel research to build greater capacity, promote creativity and engage more researchers.
  • More than 528 awards, fellowships, and grants that teach us more about diagnosing and treating Parkinson’s disease.

Download our National Research Program brochure for an overview of the National Research Program.

2017 Research Awards

As of September 2017, Parkinson Canada and its partners are proud to support 25 new grant, fellowships and student awards.

These new awards represent a total of $1,323,369 committed to support new research projects in Canada over the next two years. Including the 8 research awards in their second year, and the 25 new projects, the Parkinson Canada Research Program is currently committed to investing $1,643.369.

The new awards include:

  • 10 Pilot Project Grants
  • 3 New Investigator Awards
  • 3 Basic Research Fellowships
  • 1 Clinical Movement Disorders Fellowship
  • 1 Clinical Research Fellowship
  • 7 Graduate Student Awards

Research Program Awards for 2017-2019 (Click for PDF)

Research Funding

Financial support from individuals, corporations and foundations makes the Parkinson Canada Research Program possible. Funding for the Parkinson Canada Research Program is provided by Parkinson Canada, our regional partners and our research partners across the country.

Finding better treatments to learn more about the causes, progression, and complications of Parkinson’s.

Improving quality of life for people with Parkinson’s and their families so they can live their lives to the fullest, despite the challenges of this disease. This area of research spans a variety of health disciplines such as nursing, occupational therapy, speech language pathology and social work.

Building capacity among the next generation of Canadian researchers. We also fund specialized training for doctors in the diagnosis and management of the disease and other movement disorders so there will be more Parkinson’s specialists to provide high quality care.

Contributing on an international scale to the collective understanding of this complex disease and to the global search for a cure. Continued investments in research will produce more life-changing discoveries and bring us closer to a world without Parkinson’s disease.

Related Disorders, such as Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP) and other Parkinson’s conditions, are also funded by the Parkinson Canada Research Program.

Scientific Advisory Council

The Scientific Advisory Council (SAC) is a volunteer panel of experts which reviews funding applications to determine scientific excellence and relevance to Parkinson’s disease, providing the highest quality of objective adjudication.

  • Dr. Ron Postuma, Chair, Associate Professor of Neurology and Neurosurgery, Faculty of Medicine, McGill University; Staff neurologist, Montreal General Hospital, Researcher at the Research Institute of the McGill University Health Centre (MUHC) and at Sacré Coeur Hospital
  • Dr. Silke Appel-Cresswell, Assistant Professor, Medicine/Neurology, University of British Columbia; Clinician Scientist, Pacific Parkinson’s Research Centre and Djavad Mowafghian Centre for Brain Health
  • Dr. Frédéric Calon, Professor, Department of Pharmacy, Université Laval
  • Dr. Robert Chen, Professor of Medicine (Neurology), University of Toronto; Senior Scientist, Krembil Research Institute; Senior Scientist
  • Dr. Bin Hu, Professor, Departments of Clinical Neurosciences, Cell Biology & Anatomy, University of Calgary
  • Dr. Lorraine Kalia, Assistant Professor and Clinician-Scientist, Division of Neurology at University of Toronto; Neurologist, Movement Disorders Centre, Toronto Western Hospital
  • Dr. Wayne Martin, Professor, Division of Neurology, Movement Disorders Program, University of Alberta, Kaye Edmonton Clinic
  • Dr. Mario Masellis, Associate Scientist, Sunnybrook Health Institute; Assistant Professor, Neurology, Department of Medicine, University of Toronto
  • Dr. Abid Oueslati, Assistant Professor, Faculty of Medicine, Université Laval
  • Dr. Caroline Paquette, Assistant Professor, Department of Kinesiology and Physical Education, McGill University
  • Dr. Tamara Pringsheim, Associate Professor, with the Department of Clinical Neurosciences, Psychiatry, Pediatrics and Community Health Sciences, University of Calgary
  • Dr. Ekaterina Rogaeva, Professor, Department of Medicine, University of Toronto
  • Dr. Abbas Sadikot, Neurosurgeon, Montreal Neurological Institute, McGill University
  • Dr. Antonio Strafella, Senior Scientist, Research Imaging Centre at CAMH; Professor, Department of Medicine’s Division of Neurology at the University Health Network (UHN); Senior Scientist, Division of Brain Imaging & Behaviour Systems-Neuroscience, Toronto Western Research Institute (TWRI);, Adjunct Professor, McGill
  • Dr. Michael G. Schlossmacher, Senior Scientist, Neuroscience Program, Ottawa Hospital Research Institute; Neurologist, Division of Neurology, Department of Medicine, The Ottawa Hospital; Associate Professor of Medicine (Neurology), and Director of the MD/PhD Program, Faculty of Medicine, University of Ottawa
  • Dr. Louis-Eric Trudeau, Professor, Department of Pharmacology, Faculty of Medicine, University of Montreal
  • Dr. Jean-François Trempe, Assistant Professor, Department of Pharmacology & Therapeutics, McGill University
  • Dr. Joel Watts, Assistant Professor, Department of Biochemistry, University of Toronto; Principal Investigator, Tanz Centre for Research in Neurodegenerative Diseases (CRND)
Research Policy Committee

The Research Policy Committee (RPC) provides funding allocation recommendations to the Parkinson Canada Board of Directors. The RPC also advises the Board on policies about the most effective means to promote research into the cause(s), management, and eventual cure of Parkinson’s disease.

The Research Policy Committee (RPC) and Scientific Advisory Council (SAC) are two separate volunteer committees. The chair of the SAC also serves on the RPC to ensure continuity.

  • Dr. Pierre J. Blanchet, Chair, RPC; Neurologist, André-Barbeau Movement Disorders Unit, Hôpital Notre-Dame du CHUM, Montreal
  • Dr. Ron Postuma, Chair, SAC; Associate Professor of Neurology and Neurosurgery, Faculty of Medicine, McGill University; Staff neurologist, Montreal General Hospital, Researcher at the Research Institute of the McGill University Health Centre (MUHC) and at Sacré Coeur Hospital
  • Dr. Wendy Horbay, Vice-Chair, Independent Heath Related Strategic Planning Consultant
  • Dr. Daniel Levesque, Professor, Faculté de Pharmacie, Université de Montréal
  • Dr. Julie Nantel, Associate professor, Faculty of Health Sciences, School of Human Kinetics, University of Ottawa
  • Dr. Angela Roberts, Speech Language Pathologist, Endowed Fellow in Care of the Aging, Lawson Health Research Institutes
  • Ms. Sharon Yardley, Clinical Co-ordinator, Nurse Educator Pacific Parkinson’s Research Centre Vancouver Coastal Health – UBC site